This review proposes a striking model for Long COVID. A self sustaining loop in which lingering danger signals keep innate immunity activated, tissue injury generates new inflammatory cues, and the normal transition from inflammation to repair never fully happens.
1. After the acute infection is over, the body may still be exposed to signals that look dangerous to the innate immune system. These could include leftover SARS2 material, reactivated latent viruses, microbial products leaking across damaged mucosal barriers like the gut or nasopharynx, distress signals released by injured tissues themselves.
The immune system may keep seeing reasons to stay activated even after the original illness has passed.
2. Those danger signals are then picked up by pattern recognition receptors. The review highlights TLR2, TLR4, TLR7/8, MDA5, and the cGAS-STING pathway. Once these pathways are triggered, they drive inflammatory signaling, interferon responses, and cytokine production.
3. At the same time, damaged cells release internal alarm molecules like HMGB1, calprotectin, and mitochondrial DNA, which means the body is no longer reacting only to an outside trigger but also to damage coming from its own tissues. That creates a vicious cycle.
4. A major hub in this model is the inflammasome, especially NLRP3. The paper treats NLRP3 as a point where many different stress signals converge. Once activated, it promotes IL-1β and IL-18 release and can drive pyroptosis, an inflammatory form of cell death.
That matters because pyroptosis does not end the story. It spills more danger signals into the tissue, which can reactivate innate immune pathways again. So the loop becomes - trigger, inflammasome activation, cell injury, new danger signals, then more immune activation.
5. But the paper says the problem is not only that the immune system stays on. The second half of the model is that the body’s off-switch is broken. Normally, inflammation does not just fade away by itself.
The body actively resolves it through specialized pro-resolving mediators, by stopping neutrophil recruitment, limiting NET formation, clearing dying cells, shifting macrophages into a repair mode. In this review’s framework, those pro-resolution programs are impaired, so inflammation is not properly shut down and tissue repair does not fully begin.
6. One especially important failure point is efferocytosis, the process where macrophages clear away dying cells. If that cleanup works, the tissue can calm down and move toward repair. If it fails, those dying cells break down further and release even more inflammatory material.
The review suggests that in COVID and PASC, macrophages may fail to do this cleanup properly and may also fail to switch into a repair oriented state. Instead of helping close the wound, they stay stuck in an inflammatory program.
7. The paper then adds a deeper layer - maladaptive trained immunity. This is the idea that the innate immune system can be reprogrammed by infection. According to the review, SARS2 and the inflammatory environment around it may leave long-lasting epigenetic and metabolic marks in myeloid cells and even in hematopoietic stem and progenitor cells in the bone marrow.
So the problem is not only that some immune cells remain activated. It is that the system may keep making new immune cells already biased toward dysfunctional behavior.
8. That helps explain why Long COVID can last so long and look so different from person to person. In some patients, trained innate immunity may become hyperreactive, producing too much inflammatory signaling.
In others, the cells may become exhausted or tolerant, meaning they respond poorly in some ways but remain pathologically dysregulated. The review frames these as possible innate immune endotypes, not necessarily contradictions.
9. This endotype idea is one of the most interesting parts of the paper. Instead of treating Long COVID as one single biological entity, the authors propose that different patients may end up in different immune dominant patterns, such as thromboinflammatory, interferon-driven, or neuroinflammatory forms.
That could explain why studies often report different biomarkers and why symptoms vary so widely. It also suggests that one treatment approach may not fit everyone.
12. So in simple terms.
A lingering source of danger keeps stimulating innate immune sensors.
That drives inflammasomes, cytokines, NETs, complement, and tissue injury. The damaged tissue releases more alarm signals.
At the same time, the body fails to fully activate the systems that should resolve inflammation and promote repair.
Over time, that dysfunctional state becomes reinforced through trained immunity.
13. The big idea of the paper is this.
Long COVID may be less like a simple lingering infection and more like a failed landing after infection. The immune system cannot fully exit emergency mode, and the longer that lasts, the more the state becomes self sustaining.
This is presented as a mechanistic narrative review, not final proof of one universal cause, but it is an interesting attempt to unify many scattered findings into one framework.
Raif at al., Post-acute sequelae of COVID-19: A disorder of impaired innate immune resolution - A narrative review. sciencedirect.com/science/articl…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This is not another generic long COVID paper. It looks at patients who reached neurological care for post COVID cognitive symptoms - and finds both objective deficits and a thalamic MRI signal🧵
It looks at a very specific group - patients who ended up in neurology post-COVID clinics because of new cognitive symptoms after SARS-CoV-2 infection.
The cohort was relatively small but carefully selected.
49 post-COVID patients and 48 matched healthy controls. Median age 44, about 80% were women, and patients were tested a median of 8 months after infection. Importantly, they excluded people with prior neurological or psychiatric disease.
Long COVID may not begin only after the acute infection has passed. In at least some patients, the immune system appears to go off track from the very start. A breakthrough study.🧵
What makes this study especially interesting is that it does not just describe what patients with long COVID look like later on. Instead, it looks for differences already during acute hospitalization and then again three months later. That is its main strength - it tries to capture whether a risk immune signature is already present early.
The authors used mass cytometry with 40 markers and compared 10 patients who later developed long COVID with 13 similarly ill patients who did not.
Although this survey based study suggests some improvement over time, the burden of long COVID remains high, with millions of adults still affected and true biological recovery remaining uncertain🧵
This study analyzed data from the US National Health Interview Survey from 2022 to 2024 to examine how common long COVID is and how often people report recovering from it.
The main findings.
From 2022 to 2024, the share of US adults who reported ever having had COVID increased from 39.6% to 60.4%. Among those individuals, however, the proportion who reported ever having long COVID fell from 19.7% to 13.7%.
After SARS-CoV-2 infection, the risk of later EBV mononucleosis was higher than in people without recorded COVID-19.
A study based on nationwide Swedish registries followed nearly 10 million people🧵
10 mio people aged 3-100 years from January 1, 2020, to November 30, 2022.
The authors divided participants into those without a COVID-19 diagnosis, those with a positive PCR test without hospitalization, and those hospitalized with COVID-19.
Main finding?
After SARS2 infection, the risk of later EBV mononucleosis was higher than in people without recorded COVID-19. Among individuals with a positive PCR test who were not hospitalized, the adjusted relative risk was about 1.6 times higher, and among those hospitalized with COVID-19 it was about 5.7 times higher.
For many people, COVID did not end when the infection cleared - it evolved into a longer and far more complicated story.
This paper presents Long COVID as a heterogeneous, multisystem condition that can affect nearly every organ system🧵
This paper is a broad, wide ranging review of Long Covid. @elisaperego78 describes Long COVID as a heterogeneous, multisystem disease that can affect almost the entire body, with effects ranging from subtle or barely noticeable changes to severe disability or even death.
A key point throughout the paper is that this is not just fatigue after a viral illness, but a condition associated with measurable biological abnormalities.
In this cohort of healthcare workers infected with the original SARS2 variant, symptoms were still present even after a median of 47.5 months (!).
Brain fog may persist.
This is a prospective multicenter cohort study from Switzerland🧵
The study was designed in a fairly sensible way. The authors did not automatically treat every complaint as long COVID, but instead compared 24 chronic symptoms between the previously infected group and an uninfected control.
In this way, they identified 13 symptoms that occurred more frequently after prior infection. The most common were fatigue, smell/taste disturbance, so-called brain fog, meaning problems with concentration and cognition.